← Open Payments lookup

KEVIN KENNETT: Open Payments

NPI 1235698671 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,076 in 159 payments from 11 companies in 2025. Trend: 2023 $1,984 · 2024 $2,262 · 2025 $3,076

Food & beverage: $2,969Education: $108
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.36$856
E.R. Squibb & Sons, L.L.C.28$571
ABBVIE INC.36$489
Teva Pharmaceuticals USA, Inc.17$363
Alkermes, Inc.10$206
Vanda Pharmaceuticals Inc.8$164
Neurocrine BioSciences, Inc.8$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$147
Janssen Pharmaceuticals, Inc3$51
Axsome Therapeutics, Inc.3$48

Products named: COBENFY, REXULTI, VRAYLAR, ABILIFY MAINTENA, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, FANAPT.

Industry payments across MO — which companies pay providers there.